Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...

HealthDay News — Health officials in southern England are investigating a meningitis outbreak that has led to the deaths of 2 young people and sickened at least 11 others. Many of the cases were ...

Retatrutide is an investigational once-weekly triple hormone (glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon) receptor agonist.

Clinical benefits of the talazoparib and enzalutamide combination extend to patients with both BRCA and non-BRCA homologous recombination repair gene alterations.

HealthDay News — For patients with knee osteoarthritis (OA), the prebiotic fiber inulin and physical therapy-supported exercise (PSE) produce meaningful reductions in pain, according to a study ...

Eleven point four percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria.

Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...

Oral icotrokinra is now FDA-approved for plaque psoriasis, offering a new systemic option for adults and adolescents who weigh at least 40kg.

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK suppression.

Vaccine effectiveness was 38 to 41 percent against influenza outpatient visits, 41 percent against flu-linked hospitalization for children younger than 18 years ...